Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.99.3 (
PRE
)
1,923
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The rat is frequently used as a model to study the role of progesterone (P) in regulating FSH secretion and synthesis. The ability of P to modulate rat
FSH-beta
mRNA levels suggests the presence of a functional hormone response element. We have found three
PRE
-like sequences upstream of the transcription start site in the rat
FSH-beta
gene. These sequences are herein referred to as
PRE
-like sequence #1, #2 and #3 with #1 being most distal from the start site. The current studies determined whether these
PRE
-like sequences bound P receptor (PR) and were functional in regulating the induction of expression by P. Electrophoretic mobility shift assays (EMSA) demonstrated that a single 289 base pair (bp) DNA fragment encompassing all three
PRE
-like sequences specifically bound PR. Further, PR bound with high affinity to double-stranded oligonucleotides representing individual
PRE
-like sequences #1, #2 and, with lower affinity to a double-stranded oligonucleotide representing
PRE
-like sequence, #3. We have cloned a 361 bp sequence from the promoter region of the rat
FSH-beta
gene encompassing all three
PRE
-like sequences into a luciferase reporter vector (pGL3-promoter) yielding pFSHbeta361-luc+ which when transiently transfected into primary rat pituitary cell cultures, conferred P-responsiveness to a heterologous promoter. P-responsiveness was dependent upon the presence of PR and was blocked by the PR antagonist RU-486. These data strongly suggest the presence of functional
PRE
's in the rat
FSH-beta
gene promoter.
...
PMID:A 361 base pair region of the rat FSH-beta promoter contains multiple progesterone receptor-binding sequences and confers progesterone responsiveness. 951 69